Review of L22-GENOMICS

I. Mapping Genomes

  • Genomics employs various strategies to analyze entire genomes.

  • Genetic Maps:

    • Assign genetic landmarks (markers) to genome positions.

    • Provide relative distances between markers.

    • Linkage Mapping: Determines relative positions using genetic recombination.

  • Physical Maps:

    • Provide absolute distances between markers.

    • Include restriction maps, chromosome maps, and STS maps.

    • Can correlate with genetic maps.

    • Cloned genes can be placed on both map types.

II. Sequencing Genomes

  • Dideoxy Terminator Sequencing:

    • Essential method in genome sequencing.

    • Utilizes altered nucleotide chemistry to terminate DNA synthesis with fluorescent nucleotides.

  • Next-Generation Sequencing (NGS):

    • Employs massively parallel technologies for increased throughput.

    • Cost and time for sequencing reduced about 10,000-fold since the Human Genome Project.

    • Analyzes isolated DNA through thousands of simultaneous reactions to produce extensive data.

  • Sequenced fragments are reconstructed into complete sequences using:

    • Shotgun Sequencing: Assembles genomes from short overlapping DNA pieces.

    • Clone-Contig Sequencing: Uses larger pieces and a tiling approach for genome assembly.

III. Genome Projects

  • Human Genome Project:

    • Mapped most of the human genome and sequenced it.

    • Competitive race spurred rapid technological advances for early completion.

    • Found significantly fewer genes than initially predicted.

  • Wheat Genome Project:

    • Demonstrates improvements in genome assembly over four iterations.

    • Recent versions utilize longer reads combined with shorter, error-prone reads.

  • 1000 Genomes Project:

    • Addresses genetic diversity by sequencing over a thousand individuals.

    • Identified 80 million variants; average genome varies from reference at 4–5 million sites.

    • Up to 200 genes can be deleted without any phenotype effects.

IV. Genome Annotation and Databases

  • Genome Annotation:

    • Assigns functions to DNA sequences in genomes.

    • Identifies protein-coding genes via open reading frames.

  • Genes Comparison:

    • Infers gene function by comparing unknown genes to known genes.

  • Types of DNA Sequences Found in Human Genome:

    • Protein-Encoding Genes: About 20,000 genes scattered throughout chromosomes.

    • Introns: Predominantly noncoding DNA in each gene.

    • Segmental Duplications: Duplicated regions within the genome.

    • Pseudogenes: Inactive genes with gene-like characteristics.

    • Structural DNA: Constitutive heterochromatin near centromeres and telomeres.

    • Simple Sequence Repeats: Repeated short nucleotide sequences.

    • Transposable Elements:

      • 21% LINEs (active transposons).

      • 13% SINEs (active transposons).

      • 8% Retrotransposons (with LTRs at both ends).

      • 3% DNA transposon fossils.

    • Noncoding RNA: Regulatory RNA with many unknown functions.

V. Comparative and Functional Genomics

  • Comparative Genomics:

    • Reveals conserved regions across genomes.

    • More than half of Drosophila genes have human counterparts.

    • Cereal genomes show large regions of synteny.

  • Functional Genomics:

    • Analyzes gene function and gene products at genome level.

    • High-Throughput Approaches:

      • DNA microarrays can monitor gene expression in cells.

      • SAGE and RNA-seq analyze the transcriptome directly.

      • Proteomics: Catalogs all proteins from the genome and characterizes them;

        • Complicated by posttranslational modifications and alternative splicing.

VI. Applications of Genomics

  • Genomic data enabled the creation of the first synthetic cell.

    • Genome designed computationally and synthesized, assembled in yeast, added to a bacterium to form a new cell.

  • Genomics assists in disease identification and treatment:

    • Expands the range of diseases linked to genetics, promoting personalized medicine.

  • Raises social and ethical issues:

    • Concerns regarding synthetic cells and dangerous virus reconstruction.

    • Individual genes cannot be patented, but synthetic products (e.g., cDNA) related to the gene can be.